EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of HDAC8 mitigates AKI by reducing DNA damage and promoting homologous recombination repair

Yanjin Wang, Chao Yu, Jianjun Yu, Fengchen Shen, Xinyu Du, Na Liu iD, Shougang Zhuang iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.70114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Yanjin Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Acute Kidney Injury, Cisplatin, DNA Damage, Recombinational DNA Repair. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nephrotoxicity is a major side effect of platinum‐based antineoplastic drugs, and there is currently no available therapeutic intervention. Our study suggests that targeting histone deacetylase 8 could be a potential treatment for cisplatin‐induced acute kidney injury (AKI). In a murine model of AKI induced by cisplatin, the administration of PCI‐34051, a selective inhibitor of HDAC8, resulted in significant improvement in renal function and reduction in renal tubular damage and apoptosis. Pharmacological inhibition of HDAC8 also decreased caspase‐3 and PARP1 cleavage, attenuated Bax expression and preserved Bcl‐2 levels in the injured kidney. In cultured murine renal epithelial cells (mRTECs) exposed to cisplatin, treatment with PCI‐34051 or transfection with HDAC8 siRNA reduced apoptotic cell numbers and diminished expression of cleaved caspase‐3 and PARP1; conversely, overexpression of HDAC8 intensified these changes. Additionally, PCI‐34051 reduced p53 expression levels along with those for p21, p‐CDK2 and γ‐H2AX while preserving MRE11 expression in the injured kidney. Similarly, pharmacological and genetic inhibition of HDAC8 reduced γ‐H2AX and enhanced MRE11 expression; conversely, HDAC8 overexpression exacerbated these changes in mRTECs exposed to cisplatin. These results support that HDAC8 inhibition attenuates cisplatin‐induced AKI through a mechanism associated with reducing DNA damage and promoting its repair.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryCisplatinDNA DamageRecombinational DNA RepairHistone DeacetylasesApoptosisHistone Deacetylase InhibitorsTumor Suppressor Protein p53AnimalsMiceMaleMice, Inbred C57BLEpithelial CellsHistonesPoly (ADP-Ribose) Polymerase-1Caspase 3Repressor ProteinsMRE11 Homologue ProteinDisease Models, AnimalHydroxamic AcidsIndoles

Stichwörter der Autor:innen

DNA damageHDAC8acute kidney injuryapoptosiscisplatinhomologous recombination repair

Substanzen

CisplatinHistone DeacetylasesHDAC8 protein, mousePCI 34051Histone Deacetylase InhibitorsTumor Suppressor Protein p53HistonesPoly (ADP-Ribose) Polymerase-1Caspase 3Repressor Proteins

Autor:innen und Institutionen

  • Department of Nephrology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Department of Medicine, Rhode Island Hospital and Alpert Medical School, Brown University, Providence, Rhode Island, USA.

ORCID-Profile: Na Liu, Shougang Zhuang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, Y., Yu, C., Yu, J., Shen, F., Du, X., Liu, N., & Zhuang, S. (2024). Inhibition of HDAC8 mitigates AKI by reducing DNA damage and promoting homologous recombination repair. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70114

Vancouver

Wang Y, Yu C, Yu J, Shen F, Du X, Liu N, et al. Inhibition of HDAC8 mitigates AKI by reducing DNA damage and promoting homologous recombination repair. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70114

BibTeX
@article{Wang2024,
  author = {Wang, Yanjin and Yu, Chao and Yu, Jianjun and Shen, Fengchen and Du, Xinyu and Liu, Na and Zhuang, Shougang},
  title = {Inhibition of HDAC8 mitigates AKI by reducing DNA damage and promoting homologous recombination repair},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.70114}
}
Kostenlos starten →